Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MAGIa In-vitro- Diagnostics Medical Device Dedicated to Combined Screening of HIV, HBV, HCV and Syphilis and HBV Reflective Panels aMong Congolese pregnAnt woMen Attending to Ante Natal Care Consultations

NCT07388979 is registered in ClinicalTrials.gov with Gardiens de Vies as lead sponsor.

NCT NCT07388979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07388979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MAGIa In-vitro- Diagnostics Medical Device Dedicated to Combined Screening of HIV, HBV, HCV and Syphilis and HBV Reflective Panels aMong Congolese pregnAnt woMen Attending to Ante Natal Care Consultations
Lead sponsor
Gardiens de Vies
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
December 21, 2027
Enrollment
7,500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hbv (hepatitis b virus), hepatitis c virus (hcv), hiv - human immunodeficiency virus, mother-to-child transmission, performance, point of care sti testing, syphilis, treat b